Prognostic Implications of Hepatitis B Virus Infection in Intrahepatic Cholangiocarcinoma Treated With First-Line Gemcitabine Plus Cisplatin

International Journal of Biological Markers - Italy
doi 10.1177/1724600818777239
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

A Case of Double Primary Liver Cancer (Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma) Without Hepatitis C Virus and Hepatitis B Virus Infection

Japanese Journal of Gastroenterological Surgery
SurgeryGastroenterology
2012English

Galunisertib Plus Gemcitabine vs. Gemcitabine for First-Line Treatment of Patients With Unresectable Pancreatic Cancer

British Journal of Cancer
Cancer ResearchOncology
2018English

Prognostic Significance of Capn4 Overexpression in Intrahepatic Cholangiocarcinoma

PLoS ONE
Multidisciplinary
2013English

Intrahepatic Expression of Pre-S1 and Pre-S2 Antigens in Chronic Hepatitis B Virus Infection in Relation to Hepatitis B Virus Replication and Hepatitis Delta Virus Superinfection.

Gut
Gastroenterology
1992English

Treatment Outcomes and Prognostic Factors of Intrahepatic Cholangiocarcinoma

Oncology Reports
MedicineCancer ResearchOncology
2013English

Clinical Benefit of Maintenance Therapy for Advanced Biliary Tract Cancer Patients Showing No Progression After First-Line Gemcitabine Plus Cisplatin

Cancer Research and Treatment
Cancer ResearchOncology
2019English

Hepatitis B and C Virus Infection Is a Risk Factor for the Development of Cholangiocarcinoma

Internal Medicine
Internal MedicineMedicine
2014English

Prognostic Impact of Cirrhosis in Patients With Intrahepatic Cholangiocarcinoma Following Hepatic Resection

Canadian Journal of Gastroenterology and Hepatology
MedicineHepatologyGastroenterology
2017English

Genomic Diversity of Hepatitis B Virus Infection Associated With Fulminant Hepatitis B Development

Hepatitis Monthly
HepatologyInfectious Diseases
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy